NCT02923895View on ClinicalTrials.gov

To Investigate the Efficacy of an Occluding Dentifrice in Dentinal Hypersensitivity (DH)

PHASE4CompletedINTERVENTIONAL
Enrollment

197

Participants

Timeline

Start Date

October 11, 2016

Primary Completion Date

December 16, 2016

Study Completion Date

December 16, 2016

Conditions
Dentin Sensitivity
Interventions
OTHER

Stannous fluoride

0.454% weight by weight (w/w) stannous fluoride containing 1100 parts per million (ppm) fluoride

OTHER

Sodium monofluorophosphate

0.76% w/w sodium monofluorophosphate containing 1000 ppm fluoride

Trial Locations (1)

L4W 0C2

GSK Investigational Site, Mississauga

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT02923895 - To Investigate the Efficacy of an Occluding Dentifrice in Dentinal Hypersensitivity (DH) | Biotech Hunter | Biotech Hunter